Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a.
Saved in:
| Title: | Developing low-carbon salbutamol MDI: assessment of relative bioavailability and pharmacodynamic relative potency of salbutamol MDI with propellant HFA-152a. |
|---|---|
| Authors: | Moreira S; Clinical Pharmacology Modeling & Simulation, GSK, Collegeville, Pennsylvania, USA sebastian.a.moreira@gsk.com., Clow L; Respiratory, Immunology & Inflammation Research Unit Medicine Development Leaders, GSK, Stevenage, UK., Coles-Piper E; Global Clinical Operations Development - R&D, GSK, London, UK., Donald A; Development Biostatistics, GSK, Upper Providence, Pennsylvania, USA., Janson C; Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden., Singh D; Centre for Respiratory Medicine and Allergy, Institute of Inflammation and Repair, Manchester University NHS Foundation Trust, The University of Manchester, Manchester, UK.; Medicines Evaluation Unit, Manchester, UK., Slade D; Respiratory Clinical Research Unit, GSK, Collegeville, Pennsylvania, USA., Tiwari P; Statistics (R&D), GSK, Bengaluru, Karnataka, India., Weng S; Respiratory Biostatistics, GSK, Stevenage, UK., Plank M; Global Medical Affairs, General Medicines, GSK, Gold Coast, Queensland, Australia. |
| Source: | BMJ open respiratory research [BMJ Open Respir Res] 2026 Jun 17; Vol. 13 (1). Date of Electronic Publication: 2026 Jun 17. |
| Publication Type: | Journal Article; Clinical Trial, Phase I; Randomized Controlled Trial |
| Journal Info: | Publisher: BMJ Publishing Group Ltd & British Thoracic Society Country of Publication: England NLM ID: 101638061 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4439 (Electronic) Linking ISSN: 20524439 NLM ISO Abbreviation: BMJ Open Respir Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
